WATCH | Government could face 'tough choices' over vaccines

0:00
play article
Subscribers can listen to this article

The government could face some "tough choices" if the vaccine produced by AstraZeneca and Oxford University is found to be less effective than others, a former Department of Health director of immunisation has said.

Professor David Salisbury said ministers would need to think "very carefully" about their handling of the vaccine if its efficacy was lower than for other jabs such as those from Pfizer/BioNTech and Moderna.

The AstraZeneca/Oxford vaccine is currently being assessed by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in the UK.

Data from two arms of its phase-three trial, announced last week, gave a combined efficacy of 70%.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
Lockdown For
DAYS
HRS
MINS
Voting Booth
Will you continue to use WhatsApp following the company announcing a change terms of service which would force users to share personal data?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes, the terms of service do not bother me enough to switch
53% - 8077 votes
No, I will be switching over to a new service
43% - 6660 votes
I've never used WhatsApp
4% - 608 votes
Vote
ZAR/USD
14.95
(+1.18)
ZAR/GBP
20.35
(+1.08)
ZAR/EUR
18.13
(+0.87)
ZAR/AUD
11.53
(+0.94)
ZAR/JPY
0.14
(+1.53)
Gold
1837.08
(+0.06)
Silver
25.15
(+0.78)
Platinum
1095.99
(+1.09)
Brent Crude
54.74
(-0.64)
Palladium
2372.00
(+0.94)
All Share
63833.71
(+0.19)
Top 40
58608.31
(+0.10)
Financial 15
11969.51
(+0.55)
Industrial 25
85660.30
(+1.00)
Resource 10
62493.90
(-1.15)
All JSE data delayed by at least 15 minutes morningstar logo